true
{"AlternateComparison":false,"RelatedProducts":false,"Specification":true,"FeatureBenefit":false}
MaxZero™ Needle-free connectors MaxZero™ Needle-free Connectors

MaxZero™ Zero Reflux IV Connector

Icon to close the modal
Support
Customer Care & Ordering
Phone Icon
866 979 9408, (905 288 6000 non toll free)
Contact Us
Go next / move forward Icon
Modal Close Icon
Contact Us
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Overview

The MaxPlus™ and MaxZero™ Needle-free Connector technology is designed to help reduce the risk of infections and occlusions.

true
Features and Benefits
FEATURE AND BENEFIT CARDS NOT AVAILABLE
FEATURE AND BENEFIT CARDS NOT AVAILABLE
Promotional Story
false
Specification

GTIN - Case

50885403230194

100

GTIN - each

10885403230196

1

GTIN - Multi case

20885403230193

2400

DEHP is not part of the Material Formulation

Yes

Natural Latex

No

Registered with Health Canada

Yes

Country of Manufacture

Mexico

CE Marking

No

Case Dimensions

6in x 6in x 5in

Quantity

100

Unit of Measure

Per case

Weight

1 lbs

Product Sub Type

Priming vol <1mL

Approximate Priming Volume

0.19 mL

Manifold

None

Number of Backcheck Valves

0

Number of Connectors

1

Number of Fuses

1

Pressure Rated

Yes

Sterility

Content sterile

Stopcock

None

Color of Tubing

None

T-Connector Type

None

Number of Y-Sites

0

Y-Site Port Type

None

Type of Connector

MaxZero™

Filter

None

GTIN

GTIN - Case 50885403230194 100
GTIN - each 10885403230196 1
GTIN - Multi case 20885403230193 2400

FDA, Premarket Approval, and Regulatory

DEHP is not part of the Material Formulation Yes
Natural Latex No
Registered with Health Canada Yes

Manufacturing

Country of Manufacture Mexico
CE Marking No

Packaging

Case Dimensions 6in x 6in x 5in
Quantity 100
Unit of Measure Per case

Product Basic Specification

Weight 1 lbs
Product Sub Type Priming vol <1mL
Approximate Priming Volume 0.19 mL
Manifold None
Number of Backcheck Valves 0
Number of Connectors 1
Number of Fuses 1
Pressure Rated Yes
Sterility Content sterile
Stopcock None
Color of Tubing None
T-Connector Type None
Number of Y-Sites 0
Y-Site Port Type None
Type of Connector MaxZero™
Filter None
Electronic Instructions for Use (eIFUs)
Resources
white-papers-boosted-blue.svg
Literature

BD’s collection of literature on industry and on our offerings give you information you can use to continue striving for excellence.

Learn more
events-boosted-blue.svg
Events

BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events which excel in advancing the world of health™.

Learn more
Frequently Asked Questions
false
Related Products
RELATED PRODUCTS NOT AVAILABLE
Product Complaints
North American Regional Complaint Center
1-844-8BD-LIFE (1-844-823-5433)
productcomplaints@bd.com
Things to Consider

If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.

To better facilitate our investigation, please include the following information in your reporting:


  • Product Name and/or Catalog Number
  • Lot Number or Serial Number
  • Any injuries and/or Harm?
  • What is the issue you experienced?
  • Is the actual sample or sample representative available? (If possible, please send affected sample)
  • Contact name and phone number
References
  1. Tabak YP, Jarvis WR, Sun X, Crosby CT, Johannes RS. Meta-analysis on central line-associated bloodstream infections associated with a needleless intravenous connector with a new engineering design. Am J Infect Control. 2014;42(12):1278–1284. doi: 10.1016/j.ajic.2014.08.018.
  2. Williams A. Catheter occlusion in home infusion: the influence of needleless connector design on central catheter occlusion. J Infus Nurs. 2018;41(1):52–57. doi: 10.1097/NAN.0000000000000259.
  3. Tabak YP, Johannes RS, Sun X, Crosby CT, Jarvis WR. Innovative use of existing public and private data sources for postmarketing surveillance of central line-associated bloodstream infections associated with intravenous needleless connectors. J Infus Nurs. 2016;39(5):328–335. doi: 10.1097/NAN.0000000000000185.
  4. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics. 2008;121(5):915–923. doi: 10.1542/peds.2007-1577.
  5. Wallace MC, Macy DL. Reduction of central line-associated bloodstream infection rates in patients in the adult intensive care unit. J Infus Nurs. 2016;39(1):47–55. doi: 10.1097/NAN.0000000000000151.
  6. Sandora TJ, Graham DA, Conway M, Dodson B, Potter-Bynoe G, Margossian SP. Impact of needleless connector change frequency on central line-associated bloodstream infection rate. Am J Infect Control. 2014;42(5):485–489. doi: 10.1016/j.ajic.2014.01.022.
  7. Royer T. Implementing a better bundle to achieve and sustain a zero central line-associated bloodstream infection rate. J Infus Nurs. 2010;33(6):398–406. doi: 10.1097/NAN.0b013e3181f8586b.
  8. Casey AL, Karpanen TJ, Nightingale P, Chaganti S, Elliott TSJ. Microbiologic contamination of a positive- and a neutral-displacement needleless intravenous access device in clinical use. Am J Infect Control. 2016;44(12):1678–1680. doi: 10.1016/j.ajic.206.06.027.
  9. Clavier T, Ferguen M, Gouin P, et al. Impact of MaxZero™ needle-free connector on the incidence of central venous catheter-related infections in surgical intensive care unit. Aust Crit Care. 2019;32(2):107–111. doi: 10.1016/j.aucc.2018.03.003.
  10. Hankins R, Majorant OD, Rupp ME, et al. Microbial colonization of intravascular catheter connectors in hospitalized patients. Am J Infect Control. 2019;47(12):1489–1492. doi: 10.1016/j.ajic.2019.05.024.
  11. BD MaxPlus™ Needle-free Connector Directions for Use. 630-00658; 2015.
  12. Gorski LA, Hadaway L, Hagle ME, et al. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021;44(1S,1):S1–S224. doi: 10.1097/NAN.0000000000000396.
  13. International Nosocomial Infection Control Consortium (INICC) Care bundles to prevent central and peripheral line-related bloodstream infections. INICC website. http://www.inicc.org/media/docs/2017-INICCBSIPreventionGuidelines.pdf. Published January 1, 2017. Accessed June 2, 2021.
  14. González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117–126. doi: 10.1016/j.jhin.2013.10.008.
  15. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010;33(6):371–384.doi: 10.1097/NAN.0b013e3181f85be2.
  16. Hadaway L. Needleless connectors for IV catheters. Am J Nurs. 2012;112(11):32–44. doi: 10.1097/01.NAJ.0000422253.72836.c1.
  17. Curran E. Needleless connectors: the vascular access catheter’s microbial gatekeeper. J Infect Prev. 2016;17(5):234–240. doi: 10.1177/1757177416657164.
  18. Guenezan J, Marjanovic N, Drugeon B, et al. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial. Lancet Infect Dis. 2021. doi: 10.1016/S1473-3099(20)30738-6.

 

BD-27572        

true
true